Meghann Pine McManus
Meghann Pine McManus publishes mostly in Immunology, Hematology and Genetics, on topics such as Hemoglobinopathies and Related Disorders, Hematopoietic Stem Cell Transplantation and Acute Lymphoblastic Leukemia research.
- World rank
- #2,651,845 of 7,710,434 ranked researchers
- Rank in United States
- #775,432 of 1,627,098
- Works
- 23
- Citations
- 227
- Citations per work
- 9.9
What does Meghann Pine McManus research?
Meghann Pine McManus's work is mostly in Medicine (39%), Immunology and Microbiology (19%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences939.1%
- Medicine939.1%
- Everything else731.2%
- Life Sciences729.7%
- 1Immunology19% of their works
- 2Hematology12% of their works
- 3Genetics12% of their works
- 4Molecular Biology11% of their works
- 5Public Health, Environmental and Occupational Health8% of their works
- 6Pediatrics, Perinatology and Child Health6% of their works
Research topics
- Hemoglobinopathies and Related Disorders
- Hematopoietic Stem Cell Transplantation
- Acute Lymphoblastic Leukemia research
- Cancer therapeutics and mechanisms
- Immunodeficiency and Autoimmune Disorders
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Neuroblastoma Research and Treatments
- Lung Cancer Research Studies
Which keywords describe Meghann Pine McManus's research?
The keywords of their largest research topics: Prognostic Factors, Sickle-cell Disease, Thalassemia, Chemotherapy, Genetic Mutations, Immunotherapy, Acute Lymphoblastic Leukemia and Bone Marrow Niche.
- Topoisomerases
- Reactive Oxygen Species
- Neutrophil Extracellular Traps
- Immune Dysregulation
- DNA
- Hematopoietic Stem Cells
- Bone Marrow Niche
- Immunotherapy
- Chemotherapy
- Sickle-cell Disease
- Prognostic Factors
- Thalassemia
- Genetic Mutations
- Acute Lymphoblastic Leukemia
- Childhood Cancer
- ALK
- Genomic Profiles
- Neuroblastoma
- Primary Immunodeficiency
- Small-Cell Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Prognostic Factors72 topics
- Sickle-cell Disease71 topic
- Thalassemia71 topic
- Chemotherapy62 topics
- Genetic Mutations62 topics
- Immunotherapy62 topics
- Acute Lymphoblastic Leukemia41 topic
- Bone Marrow Niche41 topic
- Childhood Cancer41 topic
- Hematopoietic Stem Cells41 topic
- ALK31 topic
- DNA31 topic
- Genomic Profiles31 topic
- Immune Dysregulation31 topic
- Neuroblastoma31 topic
- Neutrophil Extracellular Traps31 topic
- Primary Immunodeficiency31 topic
- Reactive Oxygen Species31 topic
- Small-Cell Lung Cancer31 topic
- Topoisomerases31 topic
Where does Meghann Pine McManus work?
Meghann Pine McManus's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Meghann Pine McManus have?
OpenAlex counts 23 works and 227 citations for Meghann Pine McManus, an h-index of 8, ranking #2,651,845 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Meghann Pine McManus. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.